Establishing Next Generation Dynamic Susceptibility Contrast MRI-Based Biomarkers for Neuro-oncologic Applications
In the May NCI Imaging and Informatics Community Webinar, Dr. Chad Quarles will highlight how the improved understanding of the biophysics of contrast mechanism underlying dynamic susceptibility contrast (DSC) MRI is informing how to detect, identify, and analyze brain cancer.
DSC MRI is one of the most widely used physiologic imaging techniques in neuro-oncology. Leveraging this technique allows clinicians to differentiate between glioma grades, identify tumor components in non-enhancing glioma, and reliably detect recurrence of cancer and early therapy responses. During the presentation, Dr. Quarles will discuss how understanding DSC MRI’s biophysics has:
- standardized of acquisition protocols for multi-site clinical trials.
- led the first benchmark for software validation.
- informed development of advanced pulse sequences and analysis strategies.
This event is free and open to the public.
Dr. Quarles is a professor within and the Chair of the Division of Neuroimaging Research and the Director of the Barrow Neuroimaging Innovation Center. Dr. Quarles’s research focuses on the development and application of multimodality imaging methods for improved cancer characterization.
- HLA Class II Across The Cancer Genome Atlas Cancer DatasetOctober 27, 2021Cloud Computing Workshop: Cancer Genomics Cloud (CGC)October 28, 2021Cloud Computing Workshop: FireCloudNovember 04, 2021NCI Childhood Cancer Data Initiative Annual Symposium 2021November 09, 2021